140 related articles for article (PubMed ID: 21436773)
1. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey.
Izadi M; Taheri S
Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773
[TBL] [Abstract][Full Text] [Related]
2. More benign lymphoproliferative disease after liver transplant in infants.
Khedmat H; Ghamar-Chehreh ME; Amini M; Taheri S
Prog Transplant; 2013 Jun; 23(2):158-64. PubMed ID: 23782664
[TBL] [Abstract][Full Text] [Related]
3. Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey.
Izadi M; Taheri S
Ann Transplant; 2010; 15(4):102-9. PubMed ID: 21183884
[TBL] [Abstract][Full Text] [Related]
4. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(3):74-7. PubMed ID: 19644164
[TBL] [Abstract][Full Text] [Related]
5. Ultra-early onset post-transplantation lymphoproliferative disease.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1144-52. PubMed ID: 24231475
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow involvement by lymphoproliferative disorders post liver transplantation: PTLD Int Survey.
Khedmat H; Taheri S
Acta Med Indones; 2012 Jul; 44(3):207-13. PubMed ID: 22983075
[TBL] [Abstract][Full Text] [Related]
7. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
[TBL] [Abstract][Full Text] [Related]
8. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
Khedmat H; Taheri S
Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
[TBL] [Abstract][Full Text] [Related]
9. Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(1):10-6. PubMed ID: 21460602
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
12. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(2):73-80. PubMed ID: 21727768
[TBL] [Abstract][Full Text] [Related]
13. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
[TBL] [Abstract][Full Text] [Related]
14. Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(4):80-5. PubMed ID: 20009160
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
[TBL] [Abstract][Full Text] [Related]
17. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
[TBL] [Abstract][Full Text] [Related]
18. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
19. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
